MODD Документы SEC - Modular Medical, Inc.- Годовой отчет, доверенное заявление, проспект эмиссии

Основная статистика

CIK

1074871

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Modular Medical, Inc.

SEC Filings (Chronological Order)

На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.

August 14, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-49671 MODULAR MEDICAL, INC.
August 13, 2025	POS AM	As filed with the Securities and Exchange Commission on August 13, 2025 As filed with the Securities and Exchange Commission on August 13, 2025 Registration No.
July 2, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): June 30, 2025 MODULAR MEDICAL, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): June 30, 2025 MODULAR MEDICAL, INC. (Exact Name of Registrant as Specified in Charter) 001-41277 (Commission File Number) Nevada 87-0620495 (State or Other Jurisdiction of Incorporati
June 20, 2025	EX-4.1	Amended and Restated 2017 Equity Incentive Plan, as amended Exhibit 4.1 MODULAR MEDICAL, INC. AMENDED AND RESTATED 2017 EQUITY INCENTIVE PLAN (Effective January 23, 2020, August 11, 2021, January 17, 2023, February 13, 2024 and February 28, 2025) 1. Purposes of the Plan. The purposes of this Equity Incentive Plan are to attract and retain the best available personnel, to provide additional incentive to Employees, Directors and Consultants and to promote th
June 20, 2025	EX-14.1	Code of Business Conduct and Ethics Exhibit 14.1 MODULAR MEDICAL, INC. CODE OF BUSINESS CONDUCT AND ETHICS INTRODUCTION This Code of Business Conduct and Ethics (this “Code”) contains general guidelines for conducting the business of Modular Medical, Inc. and its subsidiaries (collectively, the “Company” or “Modular”) and applies to all of the Company’s directors, officers and employees. All officers and other employees covered by t
June 20, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: March 31, 2025 ☐ TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41277 MODULAR MEDICAL,
June 20, 2025	EX-19.1	Insider Trading Compliance Program Exhibit 19.1 MODULAR MEDICAL, INC. INSIDER TRADING COMPLIANCE PROGRAM In order to promote compliance with applicable securities regulations, known as insider trading laws, which prohibit individuals who receive or become aware of material nonpublic information (“MNPI”) about Modular Medical, Inc. (the “Company” or other companies that do business with the Company) from trading in the Company’s (or
May 28, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 22, 2025 MODULAR MEDICAL, INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 22, 2025 MODULAR MEDICAL, INC. (Exact Name of Registrant as Specified in Charter) 001-41277 (Commission File Number) Nevada 87-0620495 (State or Other Jurisdiction of Incorporatio
May 28, 2025	EX-99.1	Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors Exhibit 99.1 Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors SAN DIEGO, CA / ACCESSWIRE / May 28, 2025 / Modular Medical, Inc. (Nasdaq: MODD) (“Modular Medical” or the “Company”), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of “almost-pumpers” with its user-friendly and affordable design, today a
May 19, 2025	CORRESP	Modular Medical, Inc. 10740 Thornmint Road San Diego, California 92127 Modular Medical, Inc. 10740 Thornmint Road San Diego, California 92127 May 19, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street, N.E. Washington, DC 20549 Re: Modular Medical, Inc. Registration Statement on Form S-3, File No. 333-287313 REQUEST FOR ACCELERATION OF EFFECTIVENESS Requested Date: May 21, 2025 Requested Time: 5
May 15, 2025	S-3	As filed with the Securities and Exchange Commission on May 15, 2025 As filed with the Securities and Exchange Commission on May 15, 2025 Registration No.
May 15, 2025	EX-FILING FEES	Filing Fee Table EX-FILING FEES 4 ea023926701ex-feemodular.htm FILING FEE TABLE Exhibit 107.1 Calculation of Filing Fee Tables Form S-3 (Form Type) Modular Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maxim
May 13, 2025	424B3	Modular Medical, Inc. 20,398,891 Shares of Common Stock Filed Pursuant to Rule 424(b)(3) Registration No. 333- 286768 PROSPECTUS Modular Medical, Inc. 20,398,891 Shares of Common Stock This prospectus relates to the resale, from time to time, of up to 20,398,891 shares (the “Shares”) of our Common Stock, par value $0.001 per share (“Common Stock”), by the selling stockholders identified in this prospectus under “Selling Stockholders” (the “Offering”) p
May 6, 2025	S-3/A	As filed with the Securities and Exchange Commission on May 6, 2025 As filed with the Securities and Exchange Commission on May 6, 2025 Registration No.
May 1, 2025	CORRESP	Modular Medical, Inc. 10740 Thornmint Road San Diego, California 92127 Modular Medical, Inc. 10740 Thornmint Road San Diego, California 92127 May 1, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street, N.E. Washington, DC 20549 Re: Modular Medical, Inc. Registration Statement on Form S-3, File No. 333-286768 REQUEST FOR ACCELERATION OF EFFECTIVENESS Requested Date: May 5, 2025 Requested Time: 5:3
April 25, 2025	EX-FILING FEES	Filing Fee Table Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Modular Medical, Inc.
April 25, 2025	S-3	As filed with the Securities and Exchange Commission on April 25, 2025 As filed with the Securities and Exchange Commission on April 25, 2025 Registration No.
March 26, 2025	EX-4.2	Form of Placement Agent Warrant Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR
March 26, 2025	EX-4.1	Form of Common Stock Purchase Warrant (incorporated herein by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K filed with the SEC on March 26¸2025) Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR
March 26, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 20, 2025 MODULAR MEDICAL, I UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 20, 2025 MODULAR MEDICAL, INC. (Exact Name of Registrant as Specified in Charter) 001-41277 (Commission File Number) Nevada 87-0620495 (State or Other Jurisdiction of Incorporat
March 26, 2025	EX-10.2	Form of Subscription Agreement Exhibit 10.2 MODULAR MEDICAL, INC. SUBSCRIPTION AGREEMENT FOR UNITS (Canadian Subscribers) TO: Modular Medical, Inc. (the “Corporation”) The undersigned (the “Subscriber”) on its own behalf, and, if applicable, on behalf of the person for whom the undersigned is contracting hereunder as trustee or agent (a “Beneficial Purchaser”), hereby irrevocably subscribes for and agrees to purchase from the C
March 26, 2025	EX-10.1	Form of Securities Purchase Agreement Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of March 20, 2025, between Modular Medical, Inc., a Nevada corporation (the “Company”), and each of the purchasers identified on the signature pages hereto (each, including its successors and assigns, an “Purchaser” and collectively the “Purchasers”). RECITALS A. The Company and each Purcha
March 3, 2025	8-K	Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): February 28, 2025 MODULAR MEDICAL, INC. (Exact Name of Registrant as Specified in Charter) 001-41277 (Commission File Number) Nevada 87-0620495 (State or Other Jurisdiction of Incorpo
February 13, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐ TRANSITION REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41277 MODULAR MEDICAL, INC.
January 24, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
November 27, 2024	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No.
November 25, 2024	SC 13D/A	MODD / Modular Medical, Inc. / MANCHESTER MANAGEMENT CO LLC Activist Investment SC 13D/A 1 d1102117413d-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 8)* Modular Medical, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 60785L108 (CUSIP Number) James E. Besser c/o Manchester Management Company, LLC 2 Calle Candina, #1701 San Juan, Puerto R
November 25, 2024	EX-99.2	Modular Medical Announces Pricing of $8.2 Million Public Offering Exhibit 99.2 Modular Medical Announces Pricing of $8.2 Million Public Offering SAN DIEGO, CA/ACCESSWIRE/ November 21, 2024 - Modular Medical, Inc. (Nasdaq: MODD) (“Modular Medical” or the “Company”), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult “almost-pumpers” with its user-friendly and affordable design, today announced th
November 25, 2024	424B5	5,450,573 Shares of Common Stock MODULAR MEDICAL, INC. Filed Pursuant to Rule 424(b)(5) Registration No. 333-264193 PROSPECTUS SUPPLEMENT (To the Prospectus dated April 19, 2022) 5,450,573 Shares of Common Stock MODULAR MEDICAL, INC. We are offering 5,450,573 shares of our common stock. Our common stock is listed for trading on the Nasdaq Capital Market under the symbol “MODD.” On November 21, 2024, the last reported sale price of our common stock was
November 25, 2024	EX-99.1	Modular Medical Announces Proposed Public Offering Exhibit 99.1 Modular Medical Announces Proposed Public Offering SAN DIEGO, CA/ACCESSWIRE/ November 21, 2024 - Modular Medical, Inc. (Nasdaq: MODD) (“Modular Medical”), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult “almost-pumpers” with its user-friendly and affordable design, today announced that it has commenced an underwrit
November 25, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): November 21, 2024 MODULAR MEDICAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): November 21, 2024 MODULAR MEDICAL, INC. (Exact Name of Registrant as Specified in Charter) 001-41277 (Commission File Number) Nevada 87-0620495 (State or Other Jurisdiction of Incorpo
November 25, 2024	EX-1.1	Underwriting Agreement, dated as of November 21, 2024, between Modular Medical, Inc. and Titan Partners Group LLC Exhibit 1.1 Execution Version UNDERWRITING AGREEMENT between MODULAR MEDICAL, INC. and TITAN PARTNERS GROUP LLC, A DIVISION OF AMERICAN CAPITAL PARTNERS, LLC as Representative of the several Underwriters SHARES OF COMMON STOCK PRE-FUNDED WARRANTS TO PURCHASE SHARES OF COMMON STOCK MODULAR MEDICAL, INC. UNDERWRITING AGREEMENT New York, New York November 21, 2024 Titan Partners Group LLC, a division
November 25, 2024	EX-4.1	Form of Underwriter Warrant dated November 21, 2024 Exhibit 4.1 UNDERWRITER’S PURCHASE WARRANT MODULAR MEDICAL, INC. Warrant Shares: 381,540 Initial Exercise Date: May 21, 2025 Issue Date: November 25, 2024 This UNDERWRITER’S PURCHASE WARRANT (the “Warrant”) certifies that, for value received, American Capital Partners, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions herein
November 21, 2024	424B5	Subject to completion, dated November 21, 2024 Filed Pursuant to Rule 424(b)(5) Registration No. 333-264193 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission and is effective. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities a
November 14, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-49671 MODULAR MEDICAL, INC.
September 5, 2024	EX-99.1	Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump Exhibit 99.1 Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump ● MODD1 is a patch pump for ALL adults with Type 1 and Type 2 diabetes ● Designed to be simpler and more affordable to expand access to diabetes technology for previously underserved communities ● Commercial availability expected in early 2025 SAN DIEGO, CA / ACCESSWIRE / Sept. 4, 2024 / Modular Medical, Inc. (the “Comp
September 5, 2024	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): September 4, 2024 MODULAR MEDICAL, INC. (Exact Name of Registrant as Specified in Charter) 001-41277 (Commission File Number) Nevada 87-0620495 (State or Other Jurisdiction of Incorpo
August 27, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2024 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission Fil
August 13, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-49671 MODULAR MEDICAL, INC.
July 2, 2024	424B5	Up to $4,170,341 Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-264193 AMENDMENT NO. 1 DATED JULY 2, 2024 to Prospectus Supplement Dated November 22, 2023 (To Prospectus dated April 19, 2022) Up to $4,170,341 Common Stock This Amendment No. 1 to Prospectus Supplement (the “Amendment”) amends our prospectus supplement dated November 22, 2023, or the Prospectus Supplement. This Amendment should be read in con
June 21, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: March 31, 2024 ☐ TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41277 MODULAR MEDICAL,
June 21, 2024	EX-4.1	2017 Equity Incentive Plan, as amended and restated Exhibit 4.1 MODULAR MEDICAL, INC. AMENDED AND RESTATED 2017 EQUITY INCENTIVE PLAN (Effective January 23, 2020, August 11, 2021, January 17, 2023 and February 13, 2024) 1. Purposes of the Plan. The purposes of this Equity Incentive Plan are to attract and retain the best available personnel, to provide additional incentive to Employees, Directors and Consultants and to promote the success of the Co
June 21, 2024	EX-21.1	List of Subsidiaries Exhibit 21.1 SUBSIDIARIES OF REGISTRANT NAME JURISDICTION OF INCORPORATION Quasuras, Inc. Delaware
June 21, 2024	EX-97.1	Compensation Recovery Policy Exhibit 97.1 Modular Medical, Inc. Compensation Recovery Policy 1. Purpose. The purpose of this Compensation Recovery Policy of the Company (as amended from time to time, the “Policy”), dated as of November 30, 2023 is to describe the circumstances in which current and former Executive Officers will be required to repay or return Erroneously Awarded Compensation to members of the Company Group. Th
April 18, 2024	EX-FILING FEES	Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) MODULAR MEDICAL, INC.
April 18, 2024	S-8	As filed with the Securities and Exchange Commission on April 18, 2024 As filed with the Securities and Exchange Commission on April 18, 2024 Registration No.
April 10, 2024	EX-10.1	Third Amendment to Employment Agreement between the Company and Paul DiPerna Exhibit 10.1 THIRD AMENDMENT TO EMPLOYMENT AGREEMENT This Third Amendment to Employment Agreement (the “Third Amendment”) is made and effective as of April 8, 2024, between Modular Medical, Inc., a Nevada corporation (the “Company”), and Paul M. DiPerna (“Executive”) (each a “Party” and collectively the “Parties”). WHEREAS, the Parties entered into an Employment Agreement effective as of August 1,
April 10, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): April 8, 2024 MODULAR MEDICAL, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): April 8, 2024 MODULAR MEDICAL, INC. (Exact Name of Registrant as Specified in Charter) 001-41277 (Commission File Number) Nevada 87-0620495 (State or Other Jurisdiction of Incorporati
March 1, 2024	SC 13G	MODD / Modular Medical, Inc. / 683 Capital Management, LLC - 683 CAPITAL MANAGEMENT, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Modular Medical, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 60785L207 (CUSIP Number) February 16, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi
February 21, 2024	SC 13D/A	MODD / Modular Medical, Inc. / MANCHESTER MANAGEMENT CO LLC Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
February 20, 2024	424B5	9,090,910 Shares of Common Stock MODULAR MEDICAL, INC. Filed Pursuant to Rule 424(b)(5) Registration No. 333-264193 PROSPECTUS SUPPLEMENT (To the Prospectus dated April 19, 2022) 9,090,910 Shares of Common Stock MODULAR MEDICAL, INC. We are offering 9,090,910 shares of our common stock. Our common stock is listed for trading on the Nasdaq Capital Market under the symbol “MODD.” On February 15, 2024, the last reported sale price of our common stock was
February 16, 2024	EX-99.2	Modular Medical Announces Pricing of $10 Million Public Offering Exhibit 99.2 Modular Medical Announces Pricing of $10 Million Public Offering San Diego, CA / February 15, 2024 - Modular Medical, Inc. (Nasdaq: MODD) (“Modular Medical” or the “Company”), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that it has priced its underwritten public off
February 16, 2024	EX-1.1	Underwriting Agreement dated as of February 15, 2024 between the Company and Titan Partners Group LLC Exhibit 1.1 UNDERWRITING AGREEMENT between MODULAR MEDICAL, INC. and TITAN PARTNERS GROUP LLC, A DIVISION OF AMERICAN CAPITAL PARTNERS, LLC as Representative of the several Underwriters SHARES of Common Stock MODULAR MEDICAL, INC. UNDERWRITING AGREEMENT New York, New York February 15, 2024 Titan Partners Group LLC, a division of American Capital Partners, LLC As Representative of the several Under
February 16, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): February 15, 2024 MODULAR MEDICAL, INC. (Exact Name of Registrant as Specified in Charter) 001-41277 (Commission File Number) Nevada 87-0620495 (State or Other Jurisdiction of Incorpo
February 16, 2024	EX-99.1	Modular Medical Announces Proposed Public Offering Exhibit 99.1 Modular Medical Announces Proposed Public Offering San Diego, February 15, 2024 - Modular Medical, Inc. (Nasdaq: MODD) (“Modular Medical”), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that it has commenced an underwritten public offering (the “offering”) of shares o
February 15, 2024	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): February 13, 2024 MODULAR MEDICAL, INC. (Exact Name of Registrant as Specified in Charter) 001-41277 (Commission File Number) Nevada 87-0620495 (State or Other Jurisdiction of Incorpo
February 15, 2024	424B5	Subject to completion, dated February , 2024 Filed Pursuant to Rule 424(b)(5) Registration No. 333-264193 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission and is effective. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities a
February 15, 2024	EX-3.1	Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on February 15, 2024 Exhibit 3.1
February 14, 2024	SC 13G/A	MODD / Modular Medical, Inc. / Sio Capital Management, LLC - AMENDMENT NO. 1 Passive Investment CUSIP No. 60785L207 Page 1 of 6 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Amendment No. 1 Under the Securities Exchange Act of 1934 Modular Medical, Inc. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 60785L207 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appro
February 14, 2024	SC 13G/A	MODD / Modular Medical, Inc. / Walleye Capital LLC Passive Investment SC 13G/A 1 walleye-modd123123a1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Modular Medical, Inc (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 60785L207 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the
February 13, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-49671 MODULAR MEDICAL, INC.
January 19, 2024	EX-99.1	Modular Medical Announces 510(k) Submission of MODD1 Insulin Pump Exhibit 99.1 Modular Medical Announces 510(k) Submission of MODD1 Insulin Pump SAN DIEGO, CA / ACCESSWIRE / January 19, 2024 / Modular Medical, Inc. (Nasdaq:MODD) (“Modular Medical” or the “Company”), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced the premarket submission of its
January 19, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 19, 2024 MODULAR MEDICAL, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 19, 2024 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its chapter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission Fi
January 8, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
December 29, 2023	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
December 26, 2023	EX-99.1	Investor Presentation . NASDAQ:MODD 2 \| Forward Looking Statements, Other Disclaimers . This presentation includes forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exhibit 99.1 Investor Presentation . NASDAQ:MODD 2 \| Forward Looking Statements, Other Disclaimers . This presentation includes forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward -
December 26, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 26, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 26, 2023 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its chapter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission F
November 22, 2023	EX-1.1	Sales Agreement, dated as of November 22, 2023, between Modular Medical, Inc. and Leerink Partners LLC Exhibit 1.1 MODULAR MEDICAL, INC. Shares of Common Stock ($0.001 par value per share) SALES AGREEMENT November 22, 2023 LEERINK PARTNERS LLC 1301 Avenue of the Americas, 12th Floor New York, New York 10019 Ladies and Gentlemen: Modular Medical, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows: 1. Issuance and
November 22, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 22, 2023 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission F
November 22, 2023	424B5	Up to $6,500,000 Common Stock As Filed Pursuant to Rule 424(b)(5) Registration No. 333-264193 PROSPECTUS SUPPLEMENT (To Prospectus dated April 19, 2022) Up to $6,500,000 Common Stock We have entered into a sales agreement with Leerink Partners LLC (“Leerink Partners”) relating to shares of our common stock, par value $0.001 per share, offered by this prospectus supplement. In accordance with the terms of the sales agreement, w
November 13, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 ☐ TRANSITION REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number: 000-49671 MODULAR MEDICAL, INC.
October 5, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2023 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission Fil
October 5, 2023	EX-10.1	Modular Medical, Inc. Two-Part FDA Submission and Clearance Milestone Bonus Program Exhibit 10.1 Modular Medical, Inc. Two-Part FDA Submission and Clearance Milestone Bonus Program Modular Medical, Inc. (“Modular Medical”) is implementing a Two-Part FDA Submission and Clearance Milestone Bonus Program (the “Bonus Program”). The Bonus Program requirements are set forth below. Milestone I: All V&V testing must be completed by December 31, 2023, and submission of the 510K to the FDA
August 14, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-49671 MODULAR MEDICAL, INC.
August 14, 2023	EX-4.11	Form of Notice of Grant of Restricted Stock Unit Award and Agreement under the Amended and Restated Modular Medical, Inc. 2017 Equity Incentive Plan Exhibit 4.11 MODULAR MEDICAL, INC. AMENDED AND RESTATED 2017 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD Modular Medical, Inc. (the “Company”) hereby grants to the undersigned Participant, the following Restricted Stock Units (the “Restricted Stock Units,” the “RSUs” or the “Award”) representing shares of the Company’s Common Stock set forth below. The Award is subject to all of th
July 10, 2023	EX-99.1	Modular Medical Announces Diabetes Industry Veteran Duane DeSisto Will Join the Board of Directors Exhibit 99.1 Modular Medical Announces Diabetes Industry Veteran Duane DeSisto Will Join the Board of Directors SAN DIEGO, CA / ACCESSWIRE / July 6, 2023 / Modular Medical, Inc. (the “Company” or “Modular Medical”) (Nasdaq: MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced the
July 10, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 5, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 5, 2023 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission File N
July 3, 2023	SC 13D/A	MODD / Modular Medical Inc / MANCHESTER MANAGEMENT CO LLC Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
June 26, 2023	EX-4.7	Description of Registrant’s Securities Exhibit 4.7 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of the common stock and preferred stock of Modular Medical, Inc. (“we” or “us”) is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our second amended and restated articles of incorpora
June 26, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41277 MODULAR MEDICAL,
June 26, 2023	EX-21.1	List of Subsidiaries Exhibit 21.1 SUBSIDIARIES OF REGISTRANT NAME JURISDICTION OF INCORPORATION Quasuras, Inc. Delaware
May 17, 2023	EX-99.1	Modular Medical Announces Pricing of Upsized $9.4 Million Public Offering Exhibit 99.1 Modular Medical Announces Pricing of Upsized $9.4 Million Public Offering SAN DIEGO, CA / ACCESSWIRE / May 16, 2023 / Modular Medical, Inc. (the “Company” or “Modular Medical”) (Nasdaq: MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced the pricing of an upsized und
May 17, 2023	EX-1.1	Form of Underwriting Agreement dated May 15, 2023 Exhibit 1.1 Execution Version UNDERWRITING AGREEMENT between MODULAR MEDICAL, inC. and NEWBRIDGE SECURITIES CORPORATION Common Stock May 15, 2023 Newbridge Securities Corporation 1200 North Federal Highway, Suite 400 Boca Raton, Florida 33432 Ladies and Gentlemen: The undersigned, Modular Medical, Inc., a corporation formed under the laws of the State of Nevada (the “Company”), hereby confirms its
May 17, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2023 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission File N
May 17, 2023	424B4	PROSPECTUS 4,408,450 Units Each Unit Consisting of Two Shares of Common Stock and One Warrant to Purchase One Share of Common Stock Filed Pursuant to Rule 424(b)(4) Registration No. 333-271413 PROSPECTUS 4,408,450 Units Each Unit Consisting of Two Shares of Common Stock and One Warrant to Purchase One Share of Common Stock We are offering 4,408,450 units (each a “unit” and collectively, the “units”) of Modular Medical, Inc. (the “Company,” “Modular Medical,” “we,” “our” or “us”) with each unit consisting of two shares of our c
May 16, 2023	POS AM	As filed with the Securities and Exchange Commission on May 16, 2023 As filed with the Securities and Exchange Commission on May 16, 2023 Registration No.
May 12, 2023	S-1/A	As filed with the Securities and Exchange Commission on May 12, 2023 As filed with the Securities and Exchange Commission on May 12, 2023 Registration No.
May 12, 2023	CORRESP	May 12, 2023 May 12, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.
May 12, 2023	CORRESP	Modular Medical, Inc. 16772 W. Bernardo Drive San Diego, California 92127 Modular Medical, Inc. 16772 W. Bernardo Drive San Diego, California 92127 May 12, 2023 VIA EDGAR U.S. Securities & Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Modular Medical, Inc. Registration Statement on Form S-1 File No. 333-271413 Ladies and Gentlemen: In accordance with Rule 461 of the Securities Act of 1933, as amended, Modular Medical,
May 5, 2023	EX-4.5	Form of Warrant Exhibit 4.5 COMMON STOCK PURCHASE WARRANT MODULAR MEDICAL, inc. Warrant Shares: Initial Issue Date: , 2023 Initial Exercise Date: , 2023 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date
May 5, 2023	S-1/A	As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration No.
May 5, 2023	EX-1.1	Form of Underwriting Agreement Exhibit 1.1 UNDERWRITING AGREEMENT between MODULAR MEDICAL, inC. and NEWBRIDGE SECURITIES CORPORATION Common Stock [●], 2023 Newbridge Securities Corporation 1200 North Federal Highway, Suite 400 Boca Raton, Florida 33432 Ladies and Gentlemen: The undersigned, Modular Medical, Inc., a corporation formed under the laws of the State of Nevada (the “Company”), hereby confirms its agreement (this “Agr
May 5, 2023	EX-10.29	Form of Warrant Agency Agreement Exhibit 10.29 WARRANT AGENCY AGREEMENT This WARRANT AGENCY AGREEMENT, dated as of [], 2023 (“Agreement”), between Modular Medical, Inc., a Nevada corporation (the “Company”), and Colonial Stock Transfer Company, Inc., a New York limited liability trust company (the “Warrant Agent”). W I T N E S S E T H WHEREAS, pursuant to a registered offering by the Company of shares of common stock, par value $
May 5, 2023	EX-4.6	Form of Underwriter’s Warrant Exhibit 4.6 Underwriter’s Warrant Agreement THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOL
May 5, 2023	EX-FILING FEES	Calculation of Filing Fee Tables EXHIBIT 107 Calculation of Filing Fee Tables Form S-1 (Form Type) MODULAR MEDICAL, INC.
April 24, 2023	S-1	Power of Attorney (included in signature of previous filing) As filed with the Securities and Exchange Commission on April 24, 2023 Registration No.
April 24, 2023	EX-10.28	Standard Industrial/Commercial Single-Tenant Lease between the Registrant and Michael Summers dated January 5, 2023 Exhibit 10.28
April 24, 2023	EX-FILING FEES	Calculation of Filing Fee Tables EXHIBIT 107 Calculation of Filing Fee Tables Form S-1 (Form Type) MODULAR MEDICAL, INC.
April 24, 2023	EX-4.1	2017 Equity Incentive Plan, as amended Exhibit 4.1 MODULAR MEDICAL, INC. AMENDED AND RESTATED 2017 EQUITY INCENTIVE PLAN (Effective January 23, 2020, August 11, 2021 and January 17, 2023) 1. Purposes of the Plan. The purposes of this Equity Incentive Plan are to attract and retain the best available personnel, to provide additional incentive to Employees, Directors and Consultants and to promote the success of the Company’s business. 2
February 15, 2023	SC 13G	MODD / Modular Medical, Inc. / Walleye Capital LLC Passive Investment SC 13G 1 walleye-modd123122.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Modular Medical, Inc (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 60785L207 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the approp
February 13, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2022 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41277 MODUL
February 13, 2023	SC 13G	MODD / Modular Medical, Inc. / Sio Capital Management, LLC Passive Investment CUSIP No. 60785L108 Page 1 of 6 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Modular Medical, Inc. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 60785L108 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to de
January 19, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2023 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission Fi
January 11, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2023 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission Fil
December 20, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State
November 17, 2022	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2022 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file nu
November 14, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2022 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41277 MODU
August 11, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2022 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41277 MODULAR MEDICAL, INC.
July 26, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2022 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission File
July 26, 2022	EX-99.1	Modular Medical Appoints Kevin Schmid as Chief Operating Officer Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturing Exhibit 99.1 Modular Medical Appoints Kevin Schmid as Chief Operating Officer Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturing San Diego, CA / ACCESSWIRE / July 26, 2022 / Modular Medical, Inc. (the ?Company? or ?Modular Medical?)(NASDAQ:MODD) today announced that it has appointed industry veteran Kevin
July 26, 2022	EX-10.1	Offer Letter Agreement between the Registrant and Kevin Schmid dated July 13, 2022 Exhibit 10.1 July 13, 2022 Mr. Kevin Schmid Dear Kevin, I am pleased to offer you a position with Modular Medical, Inc. (?Modular? or the ?Company?) as Chief Operating Officer, an exempt position, reporting to the Company?s President. This offer letter (the ?Agreement?) sets forth the terms and conditions of the Company?s offer of employment. This is intended to be a binding agreement, and, if the
July 25, 2022	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2022 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission File
July 11, 2022	424B1	PROSPECTUS MODULAR MEDICAL, INC. 1,438,202 Shares of Common Stock Filed Pursuant to Rule 424(b)(1) Registration No. 333-265444 PROSPECTUS MODULAR MEDICAL, INC. 1,438,202 Shares of Common Stock This prospectus relates to the resale of up to 1,438,202 shares of common stock, par value $0.001 per share, of Modular Medical, Inc. (?we,? ?us,? ?our,? or the ?Company?), consisting of up to 1,438,202 shares of common stock issuable upon exercise of warrants (the ?May Wa
July 6, 2022	S-1/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (Amendment No. 1) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Registration No. 333-265444 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (Amendment No. 1) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 3841 87-0620495 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Num
July 6, 2022	CORRESP	* * * * July 6, 2022 VIA EDGAR United State Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.
June 28, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: March 31, 2022 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41277 MODULAR MEDICAL,
June 28, 2022	EX-4.2	Description of Securities Exhibit 4.2 DESCRIPTION OF THE REGISTRANTS? SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of the common stock and preferred stock of Modular Medical, Inc. (?we? or ?us?) is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our second amended and restated articles of incorpora
June 13, 2022	EX-99.1	Investor Presentation . NASDAQ:MODD Exhibit 99.1 Investor Presentation . NASDAQ:MODD 2 \| Forward Looking Statements, Other Disclaimers . This presentation includes forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amende d; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Fo rward
June 13, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2022 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission File
June 6, 2022	EX-FILING FEES	Calculation of Filing Fee Tables Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) MODULAR MEDICAL, INC.
June 6, 2022	S-1	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 3841 87-0620495 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Iden
June 6, 2022	EX-10.33	Severance and Release Agreement between the Registrant and Ellen O’Connor Vos dated February 23, 2022 Exhibit 10.33 SEVERANCE AGREEMENT AND GENERAL RELEASE This Severance Agreement and General Release (the ?Agreement?) dated February 23, 2022, is entered into by and between Ellen (Lynn) O?Connor Vos (?Vos?) and Modular Medical, Inc., a Nevada corporation (the ?Company?). RECITALS (a) Pursuant to an Employment Agreement effective August 11, 2021 (the ?Employment Agreement?), Vos has been employed a
May 5, 2022	EX-4.1	Form of Pre-Funded Warrant dated May 2, 2022 Exhibit 4.1 PREFUNDED COMMON STOCK PURCHASE WARRANT MODULAR MEDICAL, INC. Warrant Shares: [] Initial Exercise Date: THIS PREFUNDED COMMON STOCK PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, [PURCHASER] or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date
May 5, 2022	EX-4.2	Form of Private Placement Warrant dated May 2, 2022 Exhibit 4.2 COMMON STOCK PURCHASE WARRANT NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PU
May 5, 2022	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2022 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission File Nu
May 5, 2022	EX-99.1	Modular Medical Announces $8 Million Registered Direct Offering Exhibit 99.1 Modular Medical Announces $8 Million Registered Direct Offering SAN DIEGO, CA / ACCESSWIRE / May 3, 2022 / Modular Medical, Inc. (the ?Company? or ?Modular Medical?) (NASDAQ:MODD), today announced that it has entered into a securities purchase agreement with institutional investor Sio Capital Management (the ?Investor?) in connection with a registered direct offering of an aggregate o
May 5, 2022	EX-10.1	Form of Securities Purchase Agreement dated May 2, 2022 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of May 2, 2022, between Modular Medical, Inc., a company incorporated under the laws of Nevada (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively the ?Purchasers?). WHEREAS, subject to the
May 4, 2022	424B5	Modular Medical, Inc. 449,438 Shares of Common Stock Pre-Funded Warrants to Purchase up to 1,348,314 Shares of Common Stock Filed pursuant to Rule 424(b)(5) Registration No. 333-264193 PROSPECTUS SUPPLEMENT (To Prospectus dated April 19, 2022) Modular Medical, Inc. 449,438 Shares of Common Stock Pre-Funded Warrants to Purchase up to 1,348,314 Shares of Common Stock We are offering 449,438 shares of our Common Stock, par value $0.001 per share, or Common Stock, pursuant to this prospectus supplement and accompanying pro
April 18, 2022	CORRESP	* * * * CORRESP 1 filename1.htm April 18, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Re: Modular Medical, Inc. Registration Statement on Form S-3 Registration No. 333-264193 Request for Acceleration of Effectiveness Ladies and Gentlemen: In accordance with Rule 461 of the Securities Act of 1933, as amended, Modular Medical
April 15, 2022	S-3/A	As filed with the Securities and Exchange Commission on April 15, 2022 As filed with the Securities and Exchange Commission on April 15, 2022 Registration No.
April 8, 2022	EX-4.1	Form of Indenture Exhibit 4.1 MODULAR MEDICAL, INC. AND , TRUSTEE INDENTURE DATED AS OF , 2022 DEBT SECURITIES MODULAR MEDICAL, INC. RECONCILIATION AND TIE BETWEEN TRUST INDENTURE ACT OF 1939 AND INDENTURE, DATED AS OF , 2022 Section of Trust Indenture Act of 1939 Section(s) of Indenture ? 310(a)(1) 609 (a)(2) 609 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 609 (b) 608, 610 ? 311(a) 613 (b) 613 (c) Not Appli
April 8, 2022	S-3	As filed with the Securities and Exchange Commission on April 8, 2022 As filed with the Securities and Exchange Commission on April 8, 2022 Registration No.
April 8, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 2022 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission File
April 8, 2022	EX-FILING FEES	Calculation of Filing Fee Tables Exhibit 107.1 Calculation of Filing Fee Tables Form S-3 (Form Type) Modular Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee
February 28, 2022	SC 13D/A	MODD / Modular Medical, Inc. / MANCHESTER MANAGEMENT CO LLC Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
February 25, 2022	EX-99.1	MODULAR MEDICAL Investor Presentation. NASDAQ:MODD Exhibit 99.1 MODULAR MEDICAL Investor Presentation. NASDAQ:MODD Forward Looking Statements, Other Disclaimers. THIS SUMMARY IS PROVIDED ON A CONFIDENTIAL AND LIMITED BASIS, SOLELY FOR YOUR USE AS A PART OF YOUR DETERMINATION OF WHETHER TO INVEST IN THE OPPORTUNITY. THIS SUMMARY IS BEING PROVIDED IN RELIANCE UPON SECTION 105(C) OF THE JUMPSTART OUR BUSINESS STARTUPS ACT OF 2012 AND SEC RULE 506 OF
February 25, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2022 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its chapter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission F
February 25, 2022	EX-99.1	Modular Medical Appoints James “Jeb” Besser as Chief Executive Officer Lynn Vos to remain on board of directors Besser brings 25 years of experience in life sciences, technology, capital markets Company reaffirms timeline for 510(k) submission of MOD Exhibit 99.1 Modular Medical Appoints James ?Jeb? Besser as Chief Executive Officer Lynn Vos to remain on board of directors Besser brings 25 years of experience in life sciences, technology, capital markets Company reaffirms timeline for 510(k) submission of MODD1 insulin pump to FDA SAN DIEGO, CA, February 24, 2022 (ACCESSWIRE) ? Modular Medical, Inc. (the ?Company? or ?Modular Medical?)(Nasdaq:
February 25, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2022 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its chapter) Nevada 001-41277 87-0620495 (State or other jurisdiction of incorporation) (Commission F
February 18, 2022	SC 13D/A	MODD / Modular Medical, Inc. / MANCHESTER MANAGEMENT CO LLC Activist Investment SC 13D/A 1 d937564313d-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4)* Modular Medical, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 60785L108 (CUSIP Number) James E. Besser c/o Manchester Management Company, LLC 2 Calle Candina, #1701 San Juan, Puerto Ri
February 14, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2021 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-49671 MODULAR MEDICAL, INC.
February 14, 2022	EX-10.1	Form of Warrant Agency Agreement EXHIBIT 10.1 WARRANT AGENCY AGREEMENT This WARRANT AGENCY AGREEMENT, dated as of [], 2022 (?Agreement?), between Modular Medical, Inc., a Nevada corporation (the ?Company?), and Colonial Stock Transfer Company, Inc., a New York limited liability trust company (the ?Warrant Agent?). W I T N E S S E T H WHEREAS, pursuant to a registered offering by the Company of shares of common stock, par value $0
February 14, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2022 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its chapter) Nevada 000-49671 87-0620495 (State or other jurisdiction of incorporation) (Commission Fi
February 14, 2022	EX-4.1	Form of Warrant to Purchase Common Stock dated February 14, 2022 EXHIBIT 4.1 FORM OF WARRANT MODULAR MEDICAL, INC. WARRANT TO PURCHASE COMMON STOCK Warrant No.: Number of Shares of Common Stock: Date of Issuance: [], 2022 (?Issuance Date?) Modular Medical, Inc., a company organized under the laws of Nevada (the ?Company?), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, , the registered h
February 14, 2022	SC 13D/A	MODD / Modular Medical, Inc. / MANCHESTER MANAGEMENT CO LLC Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
February 14, 2022	EX-1.1	Form of Underwriting Agreement Exhibit 1.1 MODULAR MEDICAL, INC. [] Shares of Common Stock [] Warrants UNDERWRITING AGREEMENT [], 2022 Oppenheimer & Co. Inc. as Representative of the several Underwriters named in Schedule I hereto 85 Broad Street New York, New York 10004 Ladies and Gentlemen: Modular Medical, Inc., a Nevada corporation (the ?Company?), proposes, subject to the terms and conditions contained herein, to sell to y
February 14, 2022	EX-99.1	Modular Medical Announces Pricing of $15 Million Public Offering and Uplisting to the Nasdaq Capital Market EXHIBIT 99.1 Modular Medical Announces Pricing of $15 Million Public Offering and Uplisting to the Nasdaq Capital Market SAN DIEGO, CA, Feb. 10, 2022 (ACCESSWIRE) - Modular Medical, Inc., (Nasdaq:MODD) (the ?Company? or ?Modular Medical?), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes ca
February 11, 2022	424B4	2,500,000 Units Each Unit Consisting of One Share of Common Stock and One Warrant to Purchase One Share of Common Stock Filed Pursuant to Rule 424(b)(4) Registration No. 333-260682 PROSPECTUS 2,500,000 Units Each Unit Consisting of One Share of Common Stock and One Warrant to Purchase One Share of Common Stock We are offering 2,500,000 units (each a ?Unit? and collectively, the ?Units?), at a public offering price of $6.00 per Unit, of Modular Medical, Inc. (the ?Company,? ?Modular Medical,? ?we,? ?our? or ?us?) wi
February 9, 2022	8-A12B	Form 8-A 8-A12B 1 modular8a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A For Registration of Certain Classes of Securities Pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 87-0620495 (State or other jurisdiction of incorporation or organization) (I.R.S. Employ
February 9, 2022	S-1/A	As filed with the Securities and Exchange Commission on February 9, 2022 As filed with the Securities and Exchange Commission on February 9, 2022 Registration No.
February 8, 2022	CORRESP	OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 February 8, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Re: Modular Medical, Inc. Registration Statement on Form S-1 Registration No. 333-260682 Request for Acceleration of Effectiveness Ladies and Gentlemen: In accordance with the above-refere
February 8, 2022	CORRESP	* * * * February 8, 2022 VIA EDGAR United State Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.
February 7, 2022	EX-99.107	Calculation of Filing Fee Tables Exhibit 107 Calculation of Filing Fee Tables ????.. S-1 (Form Type) ????????????????????.. MODULAR MEDICAL, INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title (1) Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate
February 7, 2022	EX-1.1	Form of Underwriting Agreement Exhibit 1.1 MODULAR MEDICAL, INC. [] Shares of Common Stock [] Warrants UNDERWRITING AGREEMENT [], 2022 Oppenheimer & Co. Inc. as Representative of the several Underwriters named in Schedule I hereto 85 Broad Street New York, New York 10004 Ladies and Gentlemen: Modular Medical, Inc., a Nevada corporation (the ?Company?), proposes, subject to the terms and conditions contained herein, to sell to y
February 7, 2022	EX-10.31	Form of Warrant Omnibus Amendment Agreement Exhibit 10.31 OMNIBUS AMENDMENT AGREEMENT This Omnibus Amendment Agreement (this ?Amendment?), dated as of February 3, 2022, by and between MODULAR MEDICAL, INC., a Nevada corporation (the ?Company?), and each of the several purchasers signatory hereto (each such purchaser, a ?Purchaser? and, collectively, the ?Purchasers?). WHEREAS: A. The Company executed that certain Securities Purchase Agreeme
February 7, 2022	EX-4.2	Form of Warrant to Purchase Common Stock Exhibit 4.2 FORM OF WARRANT MODULAR MEDICAL, INC. WARRANT TO PURCHASE COMMON STOCK Warrant No.: Number of Shares of Common Stock: Date of Issuance: [], 2022 (?Issuance Date?) Modular Medical, Inc., a company organized under the laws of Nevada (the ?Company?), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, CEDE & CO., the re
February 7, 2022	S-1/A	As filed with the Securities and Exchange Commission on February 7, 2022 As filed with the Securities and Exchange Commission on February 7, 2022 Registration No.
February 7, 2022	EX-10.30	WARRANT AGENCY AGREEMENT Exhibit 10.30 WARRANT AGENCY AGREEMENT This WARRANT AGENCY AGREEMENT, dated as of [], 2022 (?Agreement?), between Modular Medical, Inc., a Nevada corporation (the ?Company?), and Colonial Stock Transfer Company, Inc., a New York limited liability trust company (the ?Warrant Agent?). W I T N E S S E T H WHEREAS, pursuant to a registered offering by the Company of shares of common stock, par value $
February 4, 2022	CORRESP	* * * * February 4, 2022 VIA EDGAR United State Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.
February 4, 2022	CORRESP	OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 February 4, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Re: Modular Medical, Inc. Registration Statement on Form S-1 Registration No. 333-260682 Withdrawal of Request for Acceleration of Effectiveness Ladies and Gentlemen: Reference is made to
January 28, 2022	CORRESP	* * * * January 28, 2022 VIA EDGAR United State Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.
January 28, 2022	CORRESP	OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 January 28, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Re: Modular Medical, Inc. Registration Statement on Form S-1 Registration No. 333-260682 Request for Acceleration of Effectiveness Ladies and Gentlemen: In accordance with the above-refere
January 27, 2022	CORRESP	* * * * January 27, 2022 VIA EDGAR United State Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.
January 27, 2022	CORRESP	OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 January 27, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Re: Modular Medical, Inc. Registration Statement on Form S-1 Registration No. 333-260682 Withdrawal of Request for Acceleration of Effectiveness Ladies and Gentlemen: Reference is made to
January 26, 2022	CORRESP	* * * * January 26, 2022 VIA EDGAR United State Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.
January 26, 2022	CORRESP	OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 January 26, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Re: Modular Medical, Inc. Registration Statement on Form S-1 Registration No. 333-260682 Withdrawal of Request for Acceleration of Effectiveness Ladies and Gentlemen: Reference is made to
January 26, 2022	CORRESP	* * * * January 26, 2022 VIA EDGAR United State Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.
January 26, 2022	CORRESP	OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 January 26, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Re: Modular Medical, Inc. Registration Statement on Form S-1 Registration No. 333-260682 Request for Acceleration of Effectiveness Ladies and Gentlemen: In accordance with the above-refere
January 21, 2022	CORRESP	OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 January 21, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Re: Modular Medical, Inc. Registration Statement on Form S-1 Registration No. 333-260682 Request for Acceleration of Effectiveness Ladies and Gentlemen: In accordance with the above-refere
January 21, 2022	CORRESP	* * * * January 21, 2022 VIA EDGAR United State Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.
January 20, 2022	CORRESP	* * * * CORRESP 1 filename1.htm January 20, 2022 VIA EDGAR United State Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Re: Modular Medical, Inc. Registration Statement on Form S-1 Registration No. 333-260682 Withdrawal of Request for Acceleration of Effectiveness Ladies and Gentlemen: Reference is made to our letter, filed as correspondence via E
January 20, 2022	CORRESP	OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 January 20, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Re: Modular Medical, Inc. Registration Statement on Form S-1 Registration No. 333-260682 Withdrawal of Request for Acceleration of Effectiveness Ladies and Gentlemen: Reference is made to
January 18, 2022	CORRESP	* * * * January 18, 2022 VIA EDGAR United State Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.
January 18, 2022	CORRESP	OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 January 18, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Re: Modular Medical, Inc. Registration Statement on Form S-1 Registration No. 333-260682 Request for Acceleration of Effectiveness Ladies and Gentlemen: In accordance with the above-refere
January 13, 2022	EX-1.1	Form of Underwriting Agreement EX-1.1 2 ex11.htm EXHIBIT 1.1 Exhibit 1.1 MODULAR MEDICAL, INC. [] Shares Common Stock UNDERWRITING AGREEMENT [], 2022 Oppenheimer & Co. Inc. as Representative of the several Underwriters named in Schedule I hereto 85 Broad Street New York, New York 10004 Ladies and Gentlemen: Modular Medical, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions contained herei
January 13, 2022	S-1/A	As filed with the Securities and Exchange Commission on January 13, 2022 As filed with the Securities and Exchange Commission on January 13, 2022 Registration No.
January 4, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2021 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its chapter) Nevada 000-49671 87-0620495 (State or other jurisdiction of incorporation) (Commission F
December 3, 2021	EX-99.1	Steven G. Felsher and Philip B. Sheibley Appointed to Board of Directors of Modular Medical, Inc. Exhibit 99.1 Steven G. Felsher and Philip B. Sheibley Appointed to Board of Directors of Modular Medical, Inc. San Diego, CA, November 29, 2021 ? Modular Medical, Inc. (the ?Company? or ?Modular Medical?) (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and
December 3, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2021 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its chapter) Nevada 000-49671 87-0620495 (State or other jurisdiction of incorporation) (Commission F
December 1, 2021	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 24, 2021 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its chapter) Nevada 000-49671 87-0620495 (State or other jurisdiction of incorporation) (Commission F
December 1, 2021	EX-3.1	Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on November 24, 2021 Exhibit 3.1 BARBARA K. CEGAVSKE Secretary of State KIMBERLEY PERONDI Deputy Secretary for Commercial Recordings STATE OF NEVADA OFFICE OF THE SECRETARY OF STATE Commercial Recordings Division 202 N. Carson Street Carson City, NV 89701 Telephone (775) 684-5708 Fax (775) 684-7138 North Las Vegas City Hall 2250 Las Vegas Blvd North, Suite 400 North Las Vegas, NV 89030 Telephone (702) 486-2880 Fax (70
December 1, 2021	EX-99.1	Modular Medical, Inc. Announces Reverse Stock Split in Connection with Application for Uplisting on the NASDAQ Capital Market Exhibit 99.1 Modular Medical, Inc. Announces Reverse Stock Split in Connection with Application for Uplisting on the NASDAQ Capital Market San Diego, CA, November 26, 2021 ? Modular Medical, Inc. (the ?Company?) (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinici
November 12, 2021	EX-4.1	2017 Equity Incentive Plan, as amended Exhibit 4.1 MODULAR MEDICAL, INC. AMENDED 2017 EQUITY INCENTIVE PLAN (Effective January 23, 2020 and August 11, 2021) 1. Purposes of the Plan. The purposes of this Equity Incentive Plan are to attract and retain the best available personnel, to provide additional incentive to Employees, Directors and Consultants and to promote the success of the Company?s business. 2. Definitions. As used herein,
November 12, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2021 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-49671 MODULAR MEDICAL, INC.
November 2, 2021	S-1	As filed with the Securities and Exchange Commission on November 2, 2021 As filed with the Securities and Exchange Commission on November 2, 2021 Registration No.
October 29, 2021	EX-10.28	Security Agreement dated October 28, 2021 between the Registrant and Manchester Explorer, L.P. EX-10.28 3 ex1028.htm EXHIBIT 10.28 Exhibit 10.28 SECURITY AGREEMENT THIS SECURITY AGREEMENT dated as of October 28, 2021 (this “Agreement”), is made by Modular Medical, Inc., a corporation organized under the laws of Nevada (the “Borrower”), having an address of 16722 W. Bernardo Drive, San Diego, California 92127, in favor of Manchester Explorer, L.P. (together with its successors and permitted
October 29, 2021	EX-10.27	Promissory Note dated October 28, 2021 between the Registrant and Manchester Explorer, L.P. EX-10.27 2 ex1027.htm EXHIBIT 10.27 Exhibit 10.27 PROMISSORY NOTE October 28, 2021 US$3,000,000 FOR VALUE RECEIVED, MODULAR MEDICAL, INC., a corporation incorporated under the laws of the State of Nevada and located at 16722 W. Bernardo Drive, San Diego, California 92127 (the “Borrower”), hereby promises to pay to the order of Manchester Explorer, L.P., a limited partnership organized under the la
October 29, 2021	EX-10.29	Form of Common Stock Purchase Agreement dated October 28, 2021 between the Registrant and Investors EX-10.29 4 ex1029.htm EXHIBIT 10.29 Exhibit 10.29 COMMON STOCK PURCHASE AGREEMENT This Common Stock Purchase Agreement (this “Agreement”) made as of October 28, 2021, is entered into by and between the investor set forth on the signature page hereof (the “Investor”) and Modular Medical, Inc. a Nevada corporation (the “Company”). The Company and the Investor hereby agree as follows: 1. The Investor
October 29, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 28, 2021 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-49671 87-0620495 (State or other jurisdiction of incorporation) (Commission Fi
October 13, 2021	DEF 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, For Use of the Commission Only (as Permitted by Rule 14c-5(d)(2) x Definitive Information Statement MODULAR MEDICAL, INC. (Name of Regist
October 1, 2021	PRE 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, For Use of the Commission Only (as Permitted by Rule 14c-5(d)(2) o Definitive Information Statement MODULAR MEDICAL, INC. (Name of Regist
September 30, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 29, 2021 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-49671 87-0620495 (State or other jurisdiction of incorporation) (Commission
September 30, 2021	EX-99.1	Investor Presentation. OTCQB:MODD EX-99.1 2 ex991.htm EXHIBIT 99.1 Exhibit 99.1 Investor Presentation. OTCQB:MODD Forward Looking Statements, Other Disclaimers. THIS SUMMARY IS PROVIDED ON A CONFIDENTIAL AND LIMITED BASIS, SOLELY FOR YOUR USE AS A PART OF YOUR DETERMINATION OF WHETHER TO INVEST IN THE OPPORTUNITY. THIS SUMMARY IS BEING PROVIDED IN RELIANCE UPON SECTION 105(C) OF THE JUMPSTART OUR BUSINESS STARTUPS ACT OF 2012 AND
September 17, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 14, 2021 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-49671 87-0620495 (State or other jurisdiction of incorporation) (Commission
August 16, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events 8-K 1 modular8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 11, 2021 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-49671 87-0620495 (State or other jurisdiction of i
August 16, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-49671 MODULAR MEDICAL, INC.
August 16, 2021	EX-10.27	Employment Agreement between the Registrant and Ellen O’Connor Vos dated August 11, 2021 Exhibit 10.27 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the ?Agreement?) is made and effective as of August 11, 2021, between Modular Medical, Inc., a Nevada corporation (the ?Company?), and Ellen (Lynn) O?Connor Vos (?Executive?) (each a ?Party? and collectively the ?Parties?). WHEREAS, Executive has been retained as a Board Member of Company since on or about May 2021; and WHEREAS, the Par
August 16, 2021	EX-99.1	MODULAR MEDICAL EXPANDS EXECUTIVE TEAM WITH APPOINTMENT OF LYNN O’CONNOR VOS AS NEW CEO O’Connor Vos Brings Deep Experience in Market Development, Commercializing Products and Patient Advocacy EX-99.1 3 ex991.htm EXHIBIT 99.1 Exhibit 99.1 MODULAR MEDICAL EXPANDS EXECUTIVE TEAM WITH APPOINTMENT OF LYNN O’CONNOR VOS AS NEW CEO O’Connor Vos Brings Deep Experience in Market Development, Commercializing Products and Patient Advocacy SAN DIEGO, CA / ACCESSWIRE /August 16, 2021 / Modular Medical, Inc. (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery
July 14, 2021	424B1	13,591,059 SHARES OF COMMON STOCK Filed Pursuant to Rule 424(b)(1) File No. 333-257752 PROSPECTUS 13,591,059 SHARES OF COMMON STOCK This prospectus relates to the offer and sale of up to 13,591,059 shares of our common stock, par value $0.001 per share, by the selling shareholders identified in this prospectus. The shares being offered by the selling shareholders include: ? 4,883,112 shares issuable upon conversion of promissory n
July 12, 2021	CORRESP	16772 West Bernardo Drive, San Diego, CA 92127 – 858.800.3500 – modular-medical.com July 12, 2021 VIA EDGAR United States Securities and Exchange Commission 100 F Street, NE Washington, D.
July 7, 2021	S-1	As filed with the Securities and Exchange Commission July 7, 2021 S-1 1 modulars1.htm FORM S-1 As filed with the Securities and Exchange Commission July 7, 2021 File No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 87-0620495 (State or other jurisdiction of incorporation or organizati
June 29, 2021	EX-4.2	Description of Registrant’s Securities Exhibit 4.2 DESCRIPTION OF THE REGISTRANTS? SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of the common stock and preferred stock of Modular Medical, Inc. (?we? or ?us?) is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our second amended and restated articles of incorpora
June 29, 2021	EX-10.26	Service Agreement effective May 18, 2021 between the Registrant and Ellen O’Connor Vos Exhibit 10.26 MODULAR MEDICAL, INC. BOARD OF DIRECTORS SERVICE AGREEMENT This Board of Directors Service Agreement (“Agreement”) is executed and entered into effective as of May 18, 2021, by and between Modular Medical, Inc., a Nevada corporation (the “Company”), and Ellen O’Connor Vos, an individual (“Director”), with reference to the following facts: A. The Company has requested that Director se
June 29, 2021	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2021 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-49671 MODULAR MEDICAL,
June 24, 2021	RW	16772 West Bernardo Drive, Rancho Bernardo, CA 92127 - 858.800.3500 – modular-medical.com June 21, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Application for Withdrawal by Modular Medical, Inc. of its Registration Statement on Form S-1 File No. 333-237615 Ladies and Gentlemen: Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the ?Securities Act?), Modular Medical, Inc
May 24, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 18, 2021 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-49671 87-0620495 (State or other jurisdiction of incorporation) (Commission File N
May 12, 2021	EX-99.1	Modular Medical Announces Financing EX-99.1 7 ex991.htm EXHIBIT 99.1 Exhibit 99.1 Modular Medical Announces Financing SAN DIEGO, CA May 12, 2021 — Modular Medical, Inc. (OTCQB: MODD), a medical device company focused on next generation insulin delivery technologies to widen the accessibility of insulin pumps to a greater share of people with type 1 and type 2 diabetes, announced today that it has entered into definitive agreements f
May 12, 2021	EX-2.2	Addendum No. 1 to Reorganization and Share Exchange Agreement dated as of July 24, 2017, by and among the Registrant, Quasuras, Inc., Paul DiPerna and the other Stockholders of Quasuras, Inc. dated May 3, 2021 Exhibit 2.2
May 12, 2021	EX-10.23	Form of Securities Purchase Agreement for the 2021 Private Placement EX-10.23 5 ex1023.htm EXHIBIT 10.23 Exhibit 10.23 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of , by and between MODULAR MEDICAL, INC., a Nevada corporation, with headquarters located at 16772 West Bernardo Drive, San Diego, California 92127 (the “Company”), and (the “Buyer”). WHEREAS: A. The Company and the Buyer are executing and delivering this
May 12, 2021	EX-10.22	Form of Common Stock Purchase Warrant issued in the 2021 Private Placement EX-10.22 4 ex1022.htm EXHIBIT 10.22 Exhibit 10.22 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SO
May 12, 2021	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 11, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 11, 2021 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-49671 87-0620495 (State or other jurisdiction of incorporation) (Commission File N
May 12, 2021	EX-10.24	Form of Registration Rights Agreement for the 2021 Private Placement EX-10.24 6 ex1024.htm EXHIBIT 10.24 Exhibit 10.24 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of , by and between MODULAR MEDICAL, INC., a Nevada corporation (the “Company”), and (together with permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the securities
May 12, 2021	EX-10.21	Form of Convertible Promissory Note issued in the 2021 Private Placement EX-10.21 3 ex1021.htm EXHIBIT 10.21 Exhibit 10.21 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN
March 25, 2021	EX-99.1	MODULAR MEDICAL Investor Presentation. OTCQB:MODD Exhibit 99.1 MODULAR MEDICAL Investor Presentation. OTCQB:MODD Forward Looking Statements, Other Disclaimers. THIS SUMMARY IS PROVIDED ON A CONFIDENTIAL AND LIMITED BASIS, SOLELY FOR YOUR USE AS A PART OF YOUR DETERMINATION OF WHETHER TO INVEST IN THE OPPORTUNITY. THIS SUMMARY IS BEING PROVIDED IN RELIANCE UPON SECTION 105(C) OF THE JUMPSTART OUR BUSINESS STARTUPS ACT OF 2012 AND SEC RULE 506 OF R
March 25, 2021	8-K	Financial Statements and Exhibits, Other Events 8-K 1 modular8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 24, 2021 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-49671 87-0620495 (State or other jurisdiction of in
February 12, 2021	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 or o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-49671 MODULAR MEDICAL, INC.
February 12, 2021	EX-10.21	Form of Promissory Note dated February 8, 2021 EX-10.21 2 ex1021.htm EXHIBIT 10.21 Exhibit 10.21 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR EXEMPTION FROM REGISTRATION UNDER THE FOREGOING LAWS. ACCORDINGLY, THIS NOTE AND ANY SECURITIES INTO WHICH IT MAY BE C
January 5, 2021	SC 13D/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Modular Medical, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Secur UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Modular Medical, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 60785L108 (CUSIP Number) Paul DiPerna c/o Modular Medical, Inc. 16772 West Bernardo Drive San Diego, CA 92127 (858) 800-3500 (Name, Address and
January 5, 2021	EX-99.B	Stock Transfer, Assignment and Voting Agreement Exhibit B STOCK TRANSFER, ASSIGNMENT AND VOTING AGREEMENT This STOCK TRANSFER, ASSIGNMENT AND VOTING AGREEMENT, dated December 30, 2020 (the “Effective Date”) (this “Agreement”), by and among Paul M.
January 5, 2021	EX-99.A	Joint Filing Agreement EX-99.A 2 exa.htm EXHIBIT A Exhibit A Joint Filing Agreement In accordance with Rule 13d-l(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with
November 6, 2020	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-49671 MODULAR MEDICAL, INC.
November 6, 2020	EX-4.1	2017 Equity Incentive Plan, as amended Exhibit 4.1 MODULAR MEDICAL, INC. AMENDED 2017 EQUITY INCENTIVE PLAN (Effective January 23, 2020) 1. Purposes of the Plan. The purposes of this Equity Incentive Plan are to attract and retain the best available personnel, to provide additional incentive to Employees, Directors and Consultants and to promote the success of the Company’s business. 2. Definitions. As used herein, the following defini
October 22, 2020	424B1	MODULAR MEDICAL, INC. 9,658,201 SHARES OF COMMON STOCK Filed Pursuant to Rule 424(b)(1) File No. 333-232377 PROSPECTUS MODULAR MEDICAL, INC. 9,658,201 SHARES OF COMMON STOCK This prospectus relates to the offer and sale of up to 9,658,201 shares of our common stock, par value $0.001 per share, by the selling stockholders identified in this prospectus. The shares being offered consist exclusively of: · 7,801,213 shares issued to selling stockholders in
October 14, 2020	POS AM	- POS AM As filed with the Securities and Exchange Commission on October 14, 2020 File No. 333-232377 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 87-0620495 (State or other jurisdiction of (IRS Empl
August 12, 2020	EX-10.20	Second Amendment to Employment Agreement between the Registrant and Paul DiPerna effective as of July 1, 2020 Exhibit 10.20 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT This Second Amendment to Employment Agreement (the “Second Amendment”) is made and effective as of July 1, 2020, between Modular Medical, Inc., a Nevada corporation (the “Company”), and Paul M. DiPerna (“Executive”) (each a “Party” and collectively the “Parties”). WHEREAS, the Parties entered into an Employment Agreement effective as of August
August 12, 2020	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-49671 MODULAR MEDICAL, INC.
July 31, 2020	424B3	MODULAR MEDICAL, INC. Up to 2,000,000 Preferred Units (each Preferred Unit contains one share of 13% Series A Cumulative Redeemable Perpetual Preferred Stock and three Warrants each to Purchase one share of Common Stock) Shares of Common Stock Underl Filed Pursuant to Rule 424(b)(3) File No. 333-237615 PROSPECTUS MODULAR MEDICAL, INC. Up to 2,000,000 Preferred Units (each Preferred Unit contains one share of 13% Series A Cumulative Redeemable Perpetual Preferred Stock and three Warrants each to Purchase one share of Common Stock) Shares of Common Stock Underlying the Warrants We are offering 2,000,000 preferred units (the “Preferred Units”), w
July 22, 2020	POS AM	- POS AM As filed with the Securities and Exchange Commission on July 22, 2020 File No. 333-237615 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post Effective Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 87-0620495 (State or other jurisdiction of (IRS Employe
June 29, 2020	10-K	Annual Report - FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2020 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-49671 MODULAR MEDICAL,
May 27, 2020	EX-10.18	First Amendment to Employment Agreement between the Registrant and Paul DiPerna effective as of May 12, 2020 Exhibit 10.18 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT This First Amendment to Employment Agreement (the “First Amendment”) is made and effective as of May 12, 2020, between Modular Medical, Inc., a Nevada corporation (the “Company”), and Paul M. DiPerna (“Executive”) (each a “Party” and collectively the “Parties”). WHEREAS, the Parties entered into an Employment Agreement effective as of August 1,
May 27, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 21, 2020 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-49671 87-0620495 (State or other jurisdiction of incorporation) (Commission File N
May 12, 2020	424B1	PROSPECTUS MODULAR MEDICAL, INC. Up to 2,000,000 Preferred Units (each Preferred Unit contains one share of 13% Series A Cumulative Redeemable Perpetual Preferred Stock and three Warrants each to Purchase one share of Common Stock) Shares of Common S Filed Pursuant to Rule 424(b)(1) File No. 333-237615 PROSPECTUS MODULAR MEDICAL, INC. Up to 2,000,000 Preferred Units (each Preferred Unit contains one share of 13% Series A Cumulative Redeemable Perpetual Preferred Stock and three Warrants each to Purchase one share of Common Stock) Shares of Common Stock Underlying the Warrants We are offering 2,000,000 preferred units (the “Preferred Units”), w
May 12, 2020	EX-10.1	U.S. Small Business Administration Paycheck Protection Program Note dated April 23, 2020 Exhibit 10.1 Silicon Valley Bank U.S. Small Business Administration Paycheck Protection Program Note SBA Loan No. 9920647100 SBA Loan Name Borrower Legal Name Modular Medical, Inc. DBA Date 4/23/2020 Loan Amount $ 368780 Interest Rate 1.0% per annum Borrower Modular Medical, Inc. Operating Company Not applicable Lender Silicon Valley Bank 1. PROMISE TO PAY. In return for the Loan, Borrower promise
May 12, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 24, 2020 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-49671 87-0620495 (State or other jurisdiction of incorporation) (Commission File
May 8, 2020	CORRESP	- May 8, 2020 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.
May 6, 2020	S-1/A	- FORM S-1/A As filed with the Securities and Exchange Commission on May 6, 2020 File No. 333-237615 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 87-0620495 (State or other jurisdiction of (IRS Employer incorporation o
May 1, 2020	S-1/A	- FORM S-1/A S-1/A 1 modulars1a1.htm FORM S-1/A As filed with the Securities and Exchange Commission on May 1, 2020 File No. 333-237615 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 87-0620495 (State or other jurisdicti
April 9, 2020	EX-4.2	Form of Common Stock Purchase Warrant Exhibit 4.2 COMMON STOCK PURCHASE WARRANT MODULAR MEDICAL, INC. Warrant Shares: Original Issue Date: , 2020 This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or [his][her][its] assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [•], 2020 (the “Original I
April 9, 2020	EX-4.3	Form of Warrant Agent Agreement Exhibit 4.3 WARRANT AGENT AGREEMENT THIS WARRANT AGENT AGREEMENT (this “Warrant Agent Agreement”) dated as of April , 2020 (the “Issuance Date”), by and between Modular Medical, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), and (the “Warrant Agent”). All capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in the War
April 9, 2020	EX-4.4	Form of Subscription Agreement Exhibit 4.4 MODULAR MEDICAL, INC. SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Subscription Agreement”) is dated , 2020, by and between the undersigned identified on the Signature Page hereto (the “Investor”) and Modular Medical , Inc., a Nevada corporation (the “Company”). WHEREAS, the Company has authorized the sale and issuance of 2,000,000 preferred units (the “Preferred Units”),
April 9, 2020	EX-10.17	Form of Common Stock Purchase Agreement dated March 2020 by and between the Registrant and the Investors named therein Exhibit 10.17 COMMON STOCK PURCHASE AGREEMENT by and among MODULAR MEDICAL, INC. and THE INVESTORS REFERRED TO HEREIN , 2020 COMMON STOCK PURCHASE AGREEMENT This Common Stock Purchase Agreement (this “Agreement”) is dated as of , 2020, by and among MODULAR MEDICAL, INC., a Nevada corporation (the “Company”), and each investor identified on the signature pages hereto, whether such investor is or be
April 9, 2020	EX-4.5	Form of Subscription Escrow Agreement Exhibit 4.5 SUBSCRIPTION ESCROW AGREEMENT This Subscription Escrow Agreement (this “Agreement”) is entered into and effective as of , 2020, by and among MODULAR MEDICAL, INC., a Nevada corporation (the “Company”) and TRUIST BANK, a North Carolina banking corporation (the “Escrow Agent”), W I T N E S S E T H: WHEREAS, the Company has authorized the issuance and sale of its preferred units (the “Pre
April 9, 2020	EX-3.1.1	Certificate of Designation of Preferences, Rights and Limitations of Series A Cumulative Redeemable Perpetual Preferred Stock Exhibit 3.1.1 CERTIFICATE OF DESIGNATION OF SERIES A PREFERRED STOCK, SETTING FORTH THE POWERS, PREFERENCES, RIGHTS, QUALIFICATIONS, LIMITATIONS AND RESTRICTIONS OF SUCH SERIES OF PREFERRED STOCK Pursuant to Section 78.195 of the Nevada Revised Statute, Modular Medical, Inc., a Nevada corporation (the “Corporation”), DOES HEREBY CERTIFY: The Amended and Restated Certificate of Incorporation of the
April 9, 2020	S-1	BLKE / Bear Lake Recreation, Inc. S-1 - Registration Statement - S-1 As filed with the Securities and Exchange Commission on April 8, 2020 File No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 87-0620495 (State or other jurisdiction of (IRS Employer incorporation or organization) Identif
April 9, 2020	EX-4.6	Form of Dividend Payment Escrow Agreement Exhibit 4.6 DIVIDEND PAYMENT ESCROW AGREEMENT THIS DIVIDEND PAYMENT ESCROW AGREEMENT (the “Escrow Agreement”) is entered into and effective this [·] day of [·], 2020, by and between Truist Bank, a North Carolina banking corporation (the “Escrow Agent”) and Modular Medical, Inc. (“Company”). WHEREAS, Company desires for the Escrow Agent to open an account (the “Escrow Account”) into which funds wil
March 9, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 3, 2020 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-49671 87-0620495 (State or other jurisdiction of incorporation) (Commission File
February 13, 2020	EX-10.9	Lease between MCP Socal Industrial - Bernardo, LLC and the Registrant dated January 10, 2020 Exhibit 10.9 LEASE BETWEEN MCP Socal Industrial – Bernardo, LLC (LANDLORD) AND MODULAR MEDICAL, INC. (TENANT) WEST BERNARDO BUSINESS PARK San Diego, California TABLE OF CONTENTS PAGE ARTICLE ONE - BASIC LEASE PROVISIONS 1 1.01 BASIC LEASE PROVISIONS 1 1.02 ENUMERATION OF EXHIBITS & RIDER(S) 2 1.03 DEFINITIONS 2 ARTICLE TWO - PREMISES, TERM, FAILURE TO GIVE POSSESSION, COMMON AREAS AND PARKING 6 2.
February 13, 2020	EX-10.13	Service Agreement effective December 31, 2019 between the Registrant and Carmen Volkart Exhibit 10.13 MODULAR MEDICAL, INC. BOARD OF DIRECTORS SERVICE AGREEMENT This Board of Directors Service Agreement (“Agreement”) is executed and entered into effective as of December 31, 2019, by and between Modular Medical, Inc., a Nevada corporation, (the “Company”) and Carmen B. Volkart, an individual (“Director”), with reference to the following facts: A. The Company has requested that Directo
February 13, 2020	EX-10.15	Form of Indemnification Agreement between the Registrant and each of its directors and officers used from January 23, 2020 EX-10.15 8 ex1015.htm EXHIBIT 10.15 Exhibit 10.15 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into as of , 2020 between Modular Medical, Inc., a Nevada corporation (the “Company”), and (“Indemnitee”). WITNESSETH THAT: WHEREAS, highly competent persons have become more reluctant to serve corporations as directors or in other capacities unless they
February 13, 2020	10-Q	MODD / Modular Medical, Inc. 10-Q - Quarterly Report - FORM 10-Q 10-Q 1 modular3q20.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 or o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

MODD / Modular Medical, Inc. - Документы SEC, Годовой отчет, Доверенное заявление

Основная статистика

SEC Filings

SEC Filings (Chronological Order)